T
he soil bacterium Bacillus subtilis forms architecturally complex communities of cells encased in a self-produced matrix consisting of exopolysaccharide and the amyloid-like protein TasA (1, 2) . These biofilms form on solid surfaces and at air-liquid interfaces (floating biofilms are known as pellicles). Whereas much is known about the mechanisms underlying biofilm formation, the mechanisms that cause cells to disperse from the biofilm and resume a planktonic existence are less well understood (3) . Recently, interest has focused on the production of small molecules that inhibit biofilm formation and could therefore be involved in biofilm disassembly. Of particular interest are four Damino acids (D-Leu, D-Met, D-Trp, and D-Tyr) that were found to be produced at late stages of biofilm development and were reported to have biofilm-inhibitory activity. Previous work from two of our laboratories suggested that the incorporation of these four D-amino acids into the peptidoglycan peptide side chain in place of D-Ala triggers the release of TasA fibers from the cell wall (4) .
Here, we present evidence that indicates that the D-amino acids used (D-Leu, D-Met, D-Trp, and D-Tyr) can be growth inhibitory and that the biofilm inhibition observed when the culture medium contains these D-amino acids is largely, if not entirely, a consequence of their misincorporation into protein. This finding is in keeping with the report that D-Tyr, the most potent of the four D-amino acids, is a metabolic inhibitor of B. subtilis (5) .
MATERIALS AND METHODS
Strains and growth conditions. Bacillus subtilis NCIB3610 (hereinafter, 3610) or 168 and Escherichia coli (New England BioLabs, USA) were grown in Luria-Bertani (LB) broth (10 g tryptone per liter, 5 g yeast extract per liter, 5 g NaCl per liter) or on LB agar plates containing 1.5% Bacto agar at 37°C. When appropriate, 1 g/ml erythromycin and 25 g/ml lincomycin were added to liquid or solid medium. The strains used in this study are listed in Table S1 in the supplemental material.
Strain construction. The markerless repair of dtd in B. subtilis was accomplished using the pMiniMAD protocol as described by Patrick and Kearns (6) and using primers 51 to 54, given in Table S1 in the supplemental material. Successful double-crossover events leading to the dtd ϩ strain were confirmed by restreaking individual clones on 1% agar plates containing LB, LB plus erythromycin and lincomycin, or LB plus 400 M D-LMWY. Isolates which grew on LB and on LB plus D-LMWY but not on LB plus erythromycin and lincomycin were submitted for sequencing using primers 7 and 8 (see Table S1 ).
Luciferase reporters for epsA and tapA operon expression were constructed as described previously (7) and transferred by phage transduction into dtd ϩ cells (8) . Growth measurements. Unless otherwise indicated, cells were grown to mid-exponential phase and diluted to a final optical density at 600 nm (OD 600 ) of ϳ0.015 into MSgg medium (8) to which amino acid or the equivalent volume of distilled water (dH 2 O) was added to a final volume of 20 ml. Cells were grown in shaking culture at 200 rpm at 37°C, and the OD 600 was measured every hour for 7 h. Alternatively, cells grown to mid-exponential phase were diluted 1:1,000 into MSgg plus amino acids or the equivalent volume of dH 2 O, and 250-l aliquots were transferred to a Costar polystyrene 96-well plate with a low-evaporation lid (Fisher Scientific, USA). The OD 600 was measured every 10 min for 24 h in a BioTek Synergy 2 luminometer (BioTek, USA) with continuous slow shaking at 30°C.
Pellicle assays. Cultures of B. subtilis 3610 or dtd ϩ cells were grown to early stationary phase and then diluted 1:1,000 into MSgg (9) or modified MSgg. Amino acids were stored as stock solutions of 40 mM or 60 mM in dH 2 O, except for D-Tyr and L-Tyr, which were stored as 10 mM stock solutions in 0.1 M HCl. Treatment solutions were diluted from stock solutions to achieve the final concentrations, and volumes were normalized using dH 2 O. All experiments were conducted in BD Falcon 24-well plates with low-evaporation lids (BD Biosciences, USA) in a final volume of 2 ml. Plates were incubated at 30°C or 25°C, and photographs were taken every 24 h.
Kinetic luciferase assay. Cultures of B. subtilis 3610 or dtd ϩ cells were grown in LB to mid-exponential phase and diluted 1:1,000 in fresh MSgg with amino acid treatments or an equivalent volume of dH 2 O. Dilutions were plated in triplicate (250 l each) in a 96-well polystyrene Costar plate (white with a clear bottom; Fisher Scientific, USA). Luciferase activity was measured on a BioTek Synergy 2 luminometer (BioTek, USA) with continuous slow shaking at 30°C. Luciferase luminescence was measured at a sensitivity setting of 200, and the culture optical density was measured at 600 nm every 10 min for 24 h. The final luciferase activity values were calculated by normalizing luciferase luminescence to culture density.
Evaluation of D-amino acid incorporation into peptidoglycan. Analysis of B. subtilis peptidoglycan fragments by liquid chromatographymass spectrometry (LC-MS) was performed as described by Lebar et al. (Fig. 2) .
These results indicate that competition between amino acid enantiomers influences pellicle formation. Such competition cannot occur in the peptidoglycan, as the site of noncanonical Damino acid incorporation into the peptidoglycan peptide side chain excludes molecules with an L center (11) . Rather, the specific rescue of biofilm formation by L-enantiomers suggests that Damino acids inhibit biofilm formation by interfering with protein synthesis.
Biofilm-inhibitory concentrations of D-amino acids inhibit growth. If D-amino acids affect biofilm development through an indirect effect on protein synthesis, we would expect that treatment with D-amino acids would result in a growth defect. We tested this hypothesis by measuring growth rates in the absence or presence of D-Tyr, D-Leu, or D-Trp. Growth was measured in shaking cultures at 37°C in the biofilm-inducing medium MSgg. D-Tyr, D-Leu, and D-Trp markedly inhibited growth at the concentrations used to inhibit biofilm formation (6 M, 8.5 mM, and 5 mM, respectively) (Fig. 3) . D-Tyr at 3 M caused a severe growth defect as well (S. A. Leiman, unpublished data). Moreover, growth inhibition was partially or fully reversed by the addition of an equimolar concentration of the corresponding L-enantiomer.
It is worth noting that at lower concentrations of D-amino acids (e.g., 700 M D-Leu), it is possible to uncouple pellicle inhibition and growth inhibition. Under such conditions, both the corresponding L-enantiomer and, less potently, D-Ala are capable of restoring pellicle formation (H. Vlamakis and R. Kolter, un- subtilis. We were unable to observe biofilm inhibition at this concentration, and higher concentrations sufficient to mildly inhibit pellicle formation (e.g., 500 nM) also inhibited growth (see Fig. S1 in the supplemental material). We did, however, identify conditions under which a biofilm-inhibitory concentration of D-LMWY would not inhibit growth. Biofilm inhibition occurred at a D-LMWY concentration of 300 nM each when we used a modified MSgg medium lacking the usual L-amino acid components L-phenylalanine, L-threonine, and Ltryptophan (Fig. 4A) . We detected little or no growth inhibition at this concentration in shaking culture when we used a smallerthan-usual culture volume (3 ml versus 20 ml) and a larger-thanusual inoculum (OD 600 0.05 versus 0.015) (see Fig. S2 ). Thus, there appear to be specific requirements for observing biofilm inhibition without growth inhibition. Nonetheless, under these optimized conditions, it was still possible to reverse the biofilminhibitory activity of 300 nM D-LMWY with 300 nM L-Trp (Fig.  4B) . It is also notable that D-Trp alone at 300 nM was as effective at inhibiting biofilm formation as was the D-LMWY mixture at 300 nM, a finding that is inconsistent with previous results that suggested synergy between the four D-amino acids (4). We conclude that biofilm inhibition by nanomolar concentrations of D-amino acids happens only when the medium does not contain the corresponding L-amino acids, even under conditions that minimize growth inhibition by D-amino acids.
Repairing dtd enhances survival and biofilm formation in the presence of D-amino acids. We noticed that, in the strain we routinely use (NCIB3610) and in its derivative 168, the gene (dtd) for D-Tyr-tRNA deacylase is mutated, harboring a Lys codon (AAG) in place of the wild-type initiation codon (AUG). D-TyrtRNA deacylase was originally identified on the basis of its ability to specifically remove D-Tyr from mischarged tRNA Tyr but has since been shown to deacylate tRNAs mischarged with other Damino acids (12) . Thus, for simplicity, we will henceforth refer to this enzyme as D-aminoacyl-tRNA deacylase (13) . If, as we hypothesize, the effects of D-amino acids are largely due to their misincorporation into protein, then repairing the mutant deacylase gene ought to confer resistance to the inhibitory effects of D-amino acids on growth and biofilm formation. To test this prediction, we repaired the dtd gene in 3610 using a protocol that left the chromosome unaltered except for the AAG-to-AUG nucleotide switch. Measurements of growth rates under standard biofilm-promoting conditions revealed that, unlike strain 3610, the dtd ϩ strain grew normally in the presence of D-LMWY at 3 M each (Fig. 5) . Moreover, D-LMWY at 300 M, which was lethal for the parent strain, merely slowed the growth of the strain repaired for D-aminoacyl-tRNA deacylase activity.
Importantly, whereas the parent strain produced thin biofilms in MSgg containing D-LMWY at 300 nM but lacking L-amino acids, the dtd ϩ strain formed robust pellicles under the same medium conditions (Fig. 6) . In fact, in the absence of L-amino acids, the repaired strain resisted biofilm inhibition when treated with D-LMWY at 300 M and was partially resistant to D-LMWY at 1 mM. These results reinforce the conclusion that the biofilm-inhibitory effects of D-amino acids in B. subtilis 3610 are an indirect consequence of their misincorporation into protein. (Fig. 7) . The elemental composition and structure of the peptidoglycan fragments containing D-Trp were confirmed by high-resolution LC-tandem mass spectrometry (MS/MS) (see Fig. S5 and S6 in the supplemental material). In contrast, we did not detect D-Trp in peptidoglycan from untreated dtd ϩ cells. These data indicate that repairing the dtd gene did not interfere with D-amino acid incorporation into peptidoglycan. We conclude that B. subtilis is capable of incorporating noncanonical D-amino acids, or at least D-Trp, into the peptidoglycan under conditions in which D-amino acids have little or no effect on biofilm formation or cell growth.
To summarize, the principal conclusion from our work is that inhibition of biofilm formation by noncanonical D-amino acids in B. subtilis is largely, if not entirely, mediated by misincorporation into protein, presumably resulting in proteotoxicity. This conclusion rests on the following observations: (i) the biofilm-inhibitory effects of D-amino acids at concentrations previously reported and used here were not reversed by D-Ala but were reversed by their cognate L-amino acids; (ii) the concentrations of D-amino acids that inhibited biofilm formation also inhibited growth and the expression of the matrix operons epsA and tapA, although, under specific conditions, low D-amino acid concentrations did not produce a significant growth defect; and (iii) importantly, cells corrected for the mutant D-aminoacyl-tRNA deacylase gene were re- It is curious, given the toxic effects of D-amino acids, that certain strains of B. subtilis lack D-Tyr-tRNA deacylase activity. The absence of deacylase activity in the laboratory strain 168 was discovered by Calendar and Berg in 1966 (14) . Interestingly, B. subtilis strain 23 is naturally resistant to D-Tyr, and from this observation, Champney and Jenson (5) inferred that strain 23 had retained D-Tyr-tRNA deacylase activity. Indeed, the presence of a wild-type dtd gene in this strain was later confirmed by DNA sequencing. D-Tyr-tRNA deacylase activity is not, however, the only basis for resistance to D-amino acids. In other work, we have found that when treated with lethal concentrations of D-LMWY, B. subtilis strain 3610 readily gives rise to resistant mutants that are nonetheless still have the mutant D-Tyr-tRNA deacylase gene (S. A. Leiman, unpublished data). The nature of these resistance mutations is the subject of ongoing research.
